Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02039310 · ClinicalTrials.gov registry record
Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 59
- Enrollment target
NCT02039310 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 59 participants.
The verdict
NCT02039310 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
The investigators proposes a prospective cohort study in patients with high risk bladder cancer who have opted for radical cystectomy. The investigators aim to correlate pre-operative measures of body composition, cognitive and functional status with impaired survival at 6 months after cystectomy. Impairment in this context will be a compilation of several specific objective measures including: 1) death from any cause, 2) major complication (Clavien score7 ≥ 3), 3) loss of independent living status, 4) performance status, and 5) global well-being. The study team believes that Impairment Free Survival is an important endpoint as it accounts for many aspects of a patient's functional status that might alter a patient's choice to proceed with radical surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02039310
The ClinicalTrials.gov registry entry for NCT02039310 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02039310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02039310 about?
NCT02039310 is a clinical study titled "Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy". The investigators proposes a prospective cohort study in patients with high risk bladder cancer who have opted for radical cystectomy. The investigators aim to correlate pre-operative measures of body composition, cognitive and functional status with impaired survival at 6 months after cystectomy. I...
What is the current status of trial NCT02039310?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2012-03. Estimated completion is 2015-12-31.
Who is sponsoring clinical trial NCT02039310?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.